Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

University R&D gets investor infusion

December 11, 2006 | A version of this story appeared in Volume 84, Issue 50

Biofusion, a British company dedicated to commercializing academic research, has entered a 10-year deal with Cardiff University under which it gains the right to commercialize Cardiff's research-generated intellectual property. Cardiff is taking an equity stake in Biofusion worth roughly $33 million, and Biofusion will create a dedicated investment fund of $16 million for investing in Cardiff ventures. According to Biofusion, the agreement with Cardiff triples the research spending covered by Biofusion's university agreements and expands its business into non-life-sciences research.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.